According to Evolent Health's latest financial reports and stock price the company's current Operating Margin is -8.49%. At the end of 2022 the company had an Operating Margin of -4.59%.
Year | Operating Margin | Change |
---|---|---|
2022 | -4.59% | 39.89% |
2021 | -3.28% | -90.07% |
2020 | -33.04% | -14.52% |
2019 | -38.65% | 347.55% |
2018 | -8.64% | -50.84% |
2017 | -17.57% | -81.2% |
2016 | -93.45% | -126.37% |
2015 | 354.35% | |
2013 | 78.03% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() National Healthcare
NHC | 14.84% | -274.79% | ๐บ๐ธ USA |
![]() Global Cord Blood CORBF | 48.96% | -676.68% | ๐ญ๐ฐ Hong Kong |
![]() Graham Holdings GHC | 3.10% | -136.51% | ๐บ๐ธ USA |
![]() CryoLife CRY | 0.69% | -108.12% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.